DNA Cloning

Protein Could Be Important Hepatitis B Therapy For Humans

Published in Hepatitis Weekly, November 5th, 2001

by Sonia Nichols, senior medical writer - Animal model studies indicate granulocyte-macrophage colony stimulating factor (GM-CSF) could be an effective therapy for humans infected with hepatitis B virus (HBV).

"Granulocyte-macrophage colony stimulating factor (GM-CSF) has immunoregulatory and antiviral effects, and may thus be promising for the treatment of chronic hepatitis B," Hui-Lin Wu and colleagues, National Taiwan University, explained.

GM-CSF is species specific and can be isolated in woodchucks, animals that can contract woodchuck hepatitis virus (WHV) infection, which resembles HBV infection in humans. Researchers at National Taiwan...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2001-11-05)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry